Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the ...

Creative Diagnostics has launched the Norovirus VP1 VLP Panel, a new research tool designed to support the study of norovirus ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Fascinating new research shows mollusk blood proteins have strong antimicrobial properties, especially when combined with ...

CD Bioparticles recently announced the availability of its new line of Exosome Extraction Kits. NEW YORK, NY, UNITED STATES, February 21, 2025 ...

As an alternative to antibodies, proof-of-concept of the clinical efficacy of new protein scaffolds with different pharmacological properties and less expensive manufacturing processes might also ...

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...

The DNA-protein complex is then precipitated with an antibody that is specific to ... (4 μg), similarly subjected to size selection and purification of 250–300-bp fragments, served as the ...

Q4 2024 Earnings Call Transcript February 20, 2025 Repligen Corporation beats earnings expectations. Reported EPS is $0.44, ...

Q4 2024 Earnings Call Transcript February 13, 2025 Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $2 ...